Selexipag

2-[4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)acetamide

2-{4-[(5,6-Diphenyl-2-pyrazinyl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamid

2-{4-[(5,6-Diphenyl-2-pyrazinyl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide

2-{4-[(5,6-Diphényl-2-pyrazinyl)(isopropyl)amino]butoxy}-N-(méthylsulfonyl)acétamide

2-{4-[(5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino]butoxy}-N-(methylsulfonyl)acetamide

2-{4-[(5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino]butoxy}-N-methanesulfonylacetamide

475086-01-2

5EXC0E384L

Acetamide, 2-[4-[(5,6-diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)-

Selexipag

[Wiki]

selexipag

sélexipag

selexipagum

селексипаг

سيليكسيباق

2-(4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)-N-(methylsulfonyl)acetamide

2-(4-((5,6-Diphenylpyrazinyl)(1-methylethyl)amino)butoxy)-N-(methylsulfonyl)-acetamide

2-[4-[(5,6-diphenylpyrazin-2-yl)-propan-2-ylamino]butoxy]-N-methylsulfonylacetamide

2-[4-[(5,6-diphenylpyrazinyl)(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)-acetamide

2-[4-[[5,6-di(phenyl)-2-pyrazinyl]-isopropylamino]butoxy]-N-methylsulfonylacetamide

2-[4-[[5,6-di(phenyl)pyrazin-2-yl]-isopropyl-amino]butoxy]-N-mesyl-acetamide

2-[4-[[5,6-di(phenyl)pyrazin-2-yl]-isopropyl-amino]butoxy]-N-methylsulfonyl-acetamide

2-[4-[[5,6-di(phenyl)pyrazin-2-yl]-propan-2-yl-amino]butoxy]-N-methylsulfonyl-ethanamide

2-[4-[[5,6-di(phenyl)pyrazin-2-yl]-propan-2-ylamino]butoxy]-N-methylsulfonylacetamide

2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide

2-{4-[(5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino]butoxy}-N-(methanesulfonyl)acetamide

ACT-293987::NS-304::Selexipag::Uptravi

MFCD10567093

NS 304; ACT 293987; Uptravi

ns-304(selexipag)

PI2R_HUMAN

Prostacyclin receptor

sélexipag

selexipag(ns-304)

Selexipag;ACT-293987

selexipagum

Uptravi

Uptravi®

селексипаг

سيليكسيباق